|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/22 | |
| A61K 38/26 |
| (11) | Number of the document | 1581246 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03813809.5 |
| Date of filing the European patent application | 2003-12-19 | |
| (97) | Date of publication of the European application | 2005-10-05 |
| (45) | Date of publication and mention of the grant of the patent | 2013-01-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2003/040713 |
| Date | 2003-12-19 |
| (87) | Number | WO 2004/056317 |
| Date | 2004-07-08 |
| (30) | Number | Date | Country code |
| 434888 P | 2002-12-19 | US | |
| 740146 | 2003-12-17 | US |
| (72) |
BARON, Alain, D., US
HATHAWAY, David, R., US
MISTRY, Mahesh, US
ROMAN, Richard, J., US
|
| (73) |
Amylin Pharmaceuticals, LLC,
9360 Towne Centre Drive, San Diego, CA 92121,
US
AstraZeneca Pharmaceuticals LP, 1800 Concord Pike, Wilmington, DE, US |
| (54) | COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF NEPHROPATHY |
| COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF NEPHROPATHY |